🇺🇸 FDA
Patent

US 12043667

CLEC12a binding polypeptides and uses thereof

granted A61KA61K2039/505A61K45/06

Quick answer

US patent 12043667 (CLEC12a binding polypeptides and uses thereof) held by Inhibrx Biosciences, Inc. expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx Biosciences, Inc.
Grant date
Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/505, A61K45/06, A61P, A61P35/00